Amyloidosis classification: Difference between revisions
Jump to navigation
Jump to search
(8 intermediate revisions by one other user not shown) | |||
Line 2: | Line 2: | ||
{{Amyloidosis}} | {{Amyloidosis}} | ||
{{CMG}}{{AE}}{{SHH}} | {{CMG}}{{AE}}{{HK}}{{SHH}} | ||
== Overview == | == Overview == | ||
Line 12: | Line 12: | ||
{| class="wikitable" | {| class="wikitable" | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Type | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Type | ||
!Abbreviation | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Abbreviation | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Amyloidogenic Protein/Fibril | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Amyloidogenic Protein/Fibril | ||
!Acquired/Inherited | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Acquired/Inherited | ||
!Most Common Organ Involvement | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Most Common Organ Involvement | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated Conditions | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated Conditions | ||
|- | |- | ||
Line 22: | Line 22: | ||
| | | | ||
* [[Light chain|Light chains]] of [[Immunoglobulin|immunoglobulines]] (most common type) | * [[Light chain|Light chains]] of [[Immunoglobulin|immunoglobulines]] (most common type) | ||
|Acquired | |[[Acquired disorder|Acquired]] | ||
|Heart and kidneys | |[[Heart]] and [[kidneys]] | ||
| | | | ||
* [[Monoclonal gammopathy]] | * [[Monoclonal gammopathy]] | ||
Line 31: | Line 31: | ||
| | | | ||
* [[Serum amyloid A|Serum amyloid A protein]] | * [[Serum amyloid A|Serum amyloid A protein]] | ||
|Acquired | |[[Acquired disorder|Acquired]] | ||
|Kidneys (early), heart and liver (late) | |[[Kidneys]] (early), [[heart]] and [[liver]] (late) | ||
| | | | ||
* [[Chronic inflammation|Chronic inflammatory diseases:]] | * [[Chronic inflammation|Chronic inflammatory diseases:]] | ||
Line 40: | Line 40: | ||
** Familial periodic fever syndromes | ** Familial periodic fever syndromes | ||
|- | |- | ||
| style="background:#DCDCDC;" |'''Senile systemic or wild-type amyloidosis''' | |||
|ATTRwt/ATTRvar | |||
| style="background:#DCDCDC;" |'''Senile systemic amyloidosis''' | |||
|ATTRwt | |||
| | | | ||
* Wild-type | *[[Transthyretin|Wild-type transthyretin (TTRwt)]] | ||
* Abnormal TTR gene | * Abnormal TTR gene (TTRvar) | ||
|Acquired or Hereditary | |[[Acquired disorder|Acquired]] (ATTRwt) or [[Hereditary]] (ATTRvar) | ||
|Heart and nerves (more common in hereditary type) | |[[Heart]] and [[nerves]] (more common in hereditary type) | ||
| | | | ||
* [[Senile]] [[restrictive cardiomyopathy]]/[[Transthyretin]]-related amyloidosis wild-type | * [[Senile]] [[restrictive cardiomyopathy]]/[[Transthyretin]]-related amyloidosis wild-type | ||
*ATTRwt common in males and exhibits involvement of [[ligaments]] and tenosynovium | |||
*ATTRvar may involve [[eyes]] and [[leptomeninges]] | |||
|- | |- | ||
| style="background:#DCDCDC;" |'''β2-microglobulin | | style="background:#DCDCDC;" |'''β2-microglobulin related amyloidosis''' | ||
|AH | |AH | ||
|ß2-microglobulin | | | ||
|Acquired or Hereditary | *[[Beta-2 microglobulin|ß2-microglobulin]] | ||
|Nerves (peripheral and autonomic) | |[[Acquired disorder|Acquired]] or [[Hereditary]] | ||
|[[Nerves]] ([[Peripheral nerve|peripheral]] and [[Autonomic nervous system|autonomic]]) | |||
| | | | ||
* Long-term [[hemodialysis]] | * Long-term [[hemodialysis]] | ||
|- | |- | ||
|Leucocyte cell–derived chemotaxin 2 related amyloidosis | | style="background:#DCDCDC;" |'''Leucocyte cell–derived chemotaxin 2 related amyloidosis''' | ||
|ALect2 | |ALect2 | ||
| | | | ||
* Leucocyte cell–derived chemotaxin 2 | |||
|[[Acquired disorder|Acquired]] | |||
|[[Kidneys]] and [[liver]] | |||
| | | | ||
*[[Nephrotic syndrome]] | |||
*[[Proteinuria]] | |||
* | |||
|- | |||
| style="background:#DCDCDC;" |'''Fibrinogen A alpha-chain associated amyloidosis''' | |||
|AF | |||
| | | | ||
*[[Fibrinogen]] | |||
|[[Hereditary]] | |||
|[[Kidneys]] and [[liver]] | |||
| | | | ||
* Familial [[polyneuropathy]]/[[cardiomyopathy]]/[[nephropathy]] | |||
|- | |- | ||
|Abnormal Apolipoprotein A-I related amyloidosis | | style="background:#DCDCDC;" |'''Abnormal Apolipoprotein A-I, AII, and AIV related amyloidosis''' | ||
|AApoA-I | |AApoA-I | ||
| | | | ||
* Aberrant [[apolipoprotein A-I]], [[Apolipoprotein A2|A-II]] and A-IV proteins | |||
|[[Hereditary]] | |||
|[[Kidneys]], [[liver]] and [[nerves]] ([[Peripheral nerve|peripheral]]) | |||
| | | | ||
*[[Testicular]] involvement (possible relation to [[steroidogenic]] tissues) | |||
|- | |- | ||
|Lysozyme amyloid related amyloidosis | | style="background:#DCDCDC;" |'''Lysozyme amyloid related amyloidosis''' | ||
|ALys | |ALys | ||
| | | | ||
* Aberrant [[lysozyme]] | |||
|[[Hereditary]] | |||
|[[Liver]] and [[kidneys]] | |||
| | | | ||
| | *[[Gastrointestinal tract|Gastrointestinal]] involvement | ||
|- | |- | ||
| | | style="background:#DCDCDC;" |'''Gelsolin related amyloidosis''' | ||
|AGel | |AGel | ||
| | | | ||
* Abnormal [[gelsolin]] | |||
|[[Hereditary]] | |||
|[[Kidneys]] and [[nerves]] ([[Peripheral nerve|peripheral]] and [[Cranial nerves|cranial]]) | |||
| | | | ||
| | *[[Cranial nerves|Cranial]] neuropathy | ||
|} | |} | ||
===Classification Based on Organ Involvement:<ref name="pmid26719234">{{cite journal |vauthors=Wechalekar AD, Gillmore JD, Hawkins PN |title=Systemic amyloidosis |journal=Lancet |volume=387 |issue=10038 |pages=2641–2654 |date=June 2016 |pmid=26719234 |doi=10.1016/S0140-6736(15)01274-X |url=}}</ref><ref name="pmid27634125">{{cite journal |vauthors=Falk RH, Alexander KM, Liao R, Dorbala S |title=AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy |journal=J. Am. Coll. Cardiol. |volume=68 |issue=12 |pages=1323–41 |date=September 2016 |pmid=27634125 |doi=10.1016/j.jacc.2016.06.053 |url=}}</ref>=== | ===Classification Based on Organ Involvement:<ref name="pmid26719234">{{cite journal |vauthors=Wechalekar AD, Gillmore JD, Hawkins PN |title=Systemic amyloidosis |journal=Lancet |volume=387 |issue=10038 |pages=2641–2654 |date=June 2016 |pmid=26719234 |doi=10.1016/S0140-6736(15)01274-X |url=}}</ref><ref name="pmid27634125">{{cite journal |vauthors=Falk RH, Alexander KM, Liao R, Dorbala S |title=AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy |journal=J. Am. Coll. Cardiol. |volume=68 |issue=12 |pages=1323–41 |date=September 2016 |pmid=27634125 |doi=10.1016/j.jacc.2016.06.053 |url=}}</ref>=== | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 171: | Line 183: | ||
{{WS}} | {{WS}} | ||
ocrinology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Latest revision as of 21:52, 10 December 2019
Amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Amyloidosis classification On the Web |
American Roentgen Ray Society Images of Amyloidosis classification |
Risk calculators and risk factors for Amyloidosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]Shaghayegh Habibi, M.D.[3]
Overview
Amyloidosis may be classified on the basis of type of amyloidogenic protein and associated clinical syndromes into primary (AL) amyloidosis, secondary (AA) amyloidosis, familial (AF) amyloidosis, transthyretin (ATTRwt) amyloidosis and dialysis-associated (AH) amyloidosis. It can also be classified based on extent of organ system involvement.
Classification
Classification Based on Precursor of Amyloidogenic Protein: [1][2]
Type | Abbreviation | Amyloidogenic Protein/Fibril | Acquired/Inherited | Most Common Organ Involvement | Associated Conditions |
---|---|---|---|---|---|
Primary amyloidosis | AL |
|
Acquired | Heart and kidneys | |
Secondary amyloidosis | AA | Acquired | Kidneys (early), heart and liver (late) |
| |
Senile systemic or wild-type amyloidosis | ATTRwt/ATTRvar |
|
Acquired (ATTRwt) or Hereditary (ATTRvar) | Heart and nerves (more common in hereditary type) |
|
β2-microglobulin related amyloidosis | AH | Acquired or Hereditary | Nerves (peripheral and autonomic) |
| |
Leucocyte cell–derived chemotaxin 2 related amyloidosis | ALect2 |
|
Acquired | Kidneys and liver |
|
Fibrinogen A alpha-chain associated amyloidosis | AF | Hereditary | Kidneys and liver |
| |
Abnormal Apolipoprotein A-I, AII, and AIV related amyloidosis | AApoA-I |
|
Hereditary | Kidneys, liver and nerves (peripheral) |
|
Lysozyme amyloid related amyloidosis | ALys |
|
Hereditary | Liver and kidneys |
|
Gelsolin related amyloidosis | AGel |
|
Hereditary | Kidneys and nerves (peripheral and cranial) |
|
Classification Based on Organ Involvement:[3][4]
Classification | Subtypes | Causes | Clinical Features |
---|---|---|---|
Systemic amyloidosis | Primary amyloidosis (AL) |
|
|
Secondary amyloidosis (AA) |
|
||
Hereditary amyloidosis | |||
Organ-specific amyloidosis | Renal amyloidosis |
|
|
Cardiac amyloidosis | |||
Hepatic amyloidosis |
| ||
Amyloid neuropathy | |||
Gastrointestinal amyloidosis |
|
Refrences
- ↑ Khoor A, Colby TV (February 2017). "Amyloidosis of the Lung". Arch. Pathol. Lab. Med. 141 (2): 247–254. doi:10.5858/arpa.2016-0102-RA. PMID 28134587.
- ↑ Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva M, Sekijima Y, Sipe JD, Westermark P (December 2018). "Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee". Amyloid. 25 (4): 215–219. doi:10.1080/13506129.2018.1549825. PMID 30614283. Vancouver style error: initials (help)
- ↑ Wechalekar AD, Gillmore JD, Hawkins PN (June 2016). "Systemic amyloidosis". Lancet. 387 (10038): 2641–2654. doi:10.1016/S0140-6736(15)01274-X. PMID 26719234.
- ↑ Falk RH, Alexander KM, Liao R, Dorbala S (September 2016). "AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy". J. Am. Coll. Cardiol. 68 (12): 1323–41. doi:10.1016/j.jacc.2016.06.053. PMID 27634125.
ocrinology]]